Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders

被引：0
|
作者：
Lehmann-Horn, K. [1 ]
Schleich, E. [1 ]
Hertzenberg, D. [1 ]
Hapfelmeier, A. [1 ]
Kuempfel, T. [1 ]
von Bubnhoff, N. [1 ]
Hohlfeld, R. [1 ]
Berthele, A. [1 ]
Hemmer, B. [1 ]
Weber, M. S. [1 ]
机构：
[1] Tech Univ Munich, D-80290 Munich, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1122
引用
收藏
页码：S519 / S519
页数：1
相关论文
共 50 条
  • [31] Three different B-cell depletion (anti-CD20 monoclonal antibodies) treatments for severe resistant systemic lupus erythematosus
    Faria, R. M.
    Isenberg, D. A.
    LUPUS, 2010, 19 (10) : 1256 - 1257
  • [32] Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series
    Fluge, Oystein
    Mella, Olav
    BMC NEUROLOGY, 2009, 9
  • [33] B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis
    Bruehl, Hilke
    Cihak, Josef
    Talke, Yvonne
    Gomez, Manuel Rodriguez
    Hermann, Fabian
    Goebel, Nicole
    Renner, Kerstin
    Plachy, Jiri
    Stangassinger, Manfred
    Aschermann, Susanne
    Nimmerjahn, Falk
    Mack, Matthias
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (03) : 705 - 715
  • [34] Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies
    Fagnano, Ester
    Pendharkar, Swati
    Colton, Madyson
    Jones, Philip N.
    Sallan, Marta Crespi
    Klymenko, Tetyana
    Braun, Andrejs
    Klein, Christian
    Honeychurch, Jamie
    Cheadle, Eleanor J.
    Illidge, Timothy M.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [35] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [36] Interaction of anti-CD20 antibodies and inhibitors of the B-cell receptor pathway in diffuse large B-cell lymphoma
    Peter, N.
    Zoellner, A. K.
    Zimmermann, Y.
    Hutter, G.
    Hiddemann, W.
    Dreyling, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 72 - 72
  • [37] Effect of B-cell depletion using anti-CD20 therapy on inhibitory antibody formation to human FVIII in hemophilia A mice
    Zhang, Ai-Hong
    Skupsky, Jonathan
    Scott, David W.
    BLOOD, 2011, 117 (07) : 2223 - 2226
  • [38] Effect of Subcutaneous Treatment With Anti-CD20 Antibody on B-cell Depletion in a Lipopolysaccharide-Induced Inflammatory Mouse Model
    Dawson, Janet
    Touil, Ismahane
    Scheidegger, Anja
    Vogelsanger, Melanie
    Leppert, David
    Weckbecker, Gisbert
    NEUROLOGY, 2019, 92 (15)
  • [39] B-cell depletion in patients with multiple myeloma with the anti-CD20 monoclonal antibody rituximab after high dose therapy
    Witzens, M
    Gemmel, C
    Moos, M
    Goldschmidt, H
    Ho, AD
    BONE MARROW TRANSPLANTATION, 1999, 23 : S141 - S141
  • [40] A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
    R Eisenberg
    D Albert
    J Stansberry
    D Tsai
    S Kolasinski
    S Khan
    Arthritis Res Ther, 5
12345